## BKR: Baker Hughes Company - XLE: Energy

### Executive Summary

No thesis match: MRS_10 -1.8% below STRENGTH zone (3.0-6.0%); PEG 5.22 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.5% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($46.66)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. SLB (NYSE:SLB): Evaluating Current Valuation as Long-Term Gains Pause**
- Source: Simply Wall Street | 20251130T201809 | Neutral | Relevance: 63%
- SLB (NYSE:SLB) is currently being evaluated for its valuation amidst a pause in its long-term gains despite recent share price increases. The company is considered 20.1% undervalued with a fair value of $45.37, driven by expected profit margin acceleration and business transformation, including synergies from the ChampionX integration. However, macroeconomic uncertainties and integration delays pose risks to this positive outlook.

**2. Is Halliburton’s (HAL) Board Refresh and Dividend Move a Signal on Its Governance Strategy?**
- Source: Simply Wall Street | 20251202T203146 | Neutral | Relevance: 62%
- Halliburton recently appointed Timothy A. Leach to its board of directors and announced a Q4 2025 dividend of US$0.17 per share. This move signals the company's focus on strong governance and sustainable capital management. The article discusses how these changes, alongside international contract wins like those with Petrobras, support Halliburton’s long-term investment narrative and efforts to diversify away from North American shale markets.

**3. Is SLB’s Valuation Attractive After Recent Global Energy Transition Partnerships?**
- Source: Simply Wall Street | 20251202T193212 | Neutral | Relevance: 60%
- This article analyzes SLB's valuation following recent global energy transition partnerships, concluding that the stock appears undervalued. Using a Discounted Cash Flow (DCF) analysis, SLB's intrinsic value is estimated at $91.95 per share, representing a 60.2% discount from its current price. Additionally, its current P/E ratio of 15x is below both industry and peer averages, further suggesting undervaluation based on adjusted fundamentals.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-20 | Jefferies | $59 | $58 | +2% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-20 | Jefferies | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 5 ($1.62M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 77.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- JPMORGAN CHASE & CO: 24.9% (+85.7%)
- Vanguard Group Inc: 14.9% (+0.5%)
- Blackrock Inc.: 11.0% (-1.4%)
- State Street Corpora: 7.3% (-1.9%)
- Capital World Invest: 5.7% (+7.1%)

### Key Risks

1. Valuation stretched: PEG 5.2x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 5.22 signals overvaluation risk, limited margin of safety. Forward P/E 18.4x stretched relative to 9% growth. Insider selling cluster ($1.6M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $47.4B |
| Beta | 0.89 |
| 52W Range | $33.60 - $51.12 |
| Short Interest | 3.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 5.22 |
| Forward P/E | 18.4 |
| Current P/E | 20.0 |
| YoY Growth | 8.7% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 0.7% to -1.8% (-2.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.8pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 57.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.79% (CS: 40) | Neutral |
| RSI_14 | 56.7 | Neutral |
| MACD Histogram | 0.13 | Bullish |
| vs SMA20 | 1.021x | Above |
| vs SMA50 | 1.030x | Above |
| vs SMA200 | 1.153x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $49.48
- **Stop Loss:** $46.66 (5.7% risk)
- **Target:** $52.30 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 177
- **Position Value:** $8,757.96
- **Portfolio %:** 8.76%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-01-29 (Est: $0.67)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.62 | $0.68 | +9.3% |
| 2025Q2 | $0.55 | $0.63 | +13.6% |
| 2025Q1 | $0.47 | $0.51 | +7.6% |
| 2024Q4 | $0.63 | $0.70 | +11.8% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*